abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

3 Jun 2004

Author:
David Teather & Sarah Boseley, Guardian [UK]

Glaxo faces drug fraud lawsuit - Firm accused of keeping back negative trial results [USA]

Britain's biggest drug company, GlaxoSmithKline, is facing fraud charges in the United States for allegedly concealing information that its leading antidepressant caused suicidal behaviour among children and teenagers during clinical trials...A GSK spokesman said the firm had not had a chance to examine the lawsuit in detail. But he denied there had been a cover-up.